HDAC8 and urothelial carcinoma: Fourth, HDAC8 may lose its oncogenic effects in specific cancer types, such as uroepithelial carcinoma, in which its procarcinogenic effects are limited.[40] Thus, for cancer patients on a high‐PA diet, it may be necessary to consider the cancer type before selecting PCI‐34051 as the treatment method.